A 28-year-old pregnant woman at 16 weeks of gestation is on warfarin for mechanical mitral valve replacement. Which feature best distinguishes warfarin embryopathy from fetal warfarin syndrome in terms of timing and clinical presentation?

Explanation

## Warfarin Embryopathy vs. Fetal Warfarin Syndrome ### Critical Distinction: Timing and Manifestations **Key Point:** Warfarin embryopathy and fetal warfarin syndrome are two distinct teratogenic syndromes caused by warfarin exposure at different gestational periods, with different clinical phenotypes. ### Comparison Table | Feature | Warfarin Embryopathy | Fetal Warfarin Syndrome | |---------|---|---| | **Exposure Period** | First trimester (6–12 weeks) | Second and third trimesters | | **Incidence** | 1–2% with first-trimester exposure | Variable; depends on timing and intensity | | **Nasal Hypoplasia** | Yes (characteristic) | No | | **Skeletal Abnormalities** | Yes (stippled epiphyses, bone hypoplasia) | No | | **CNS Abnormalities** | No | Yes (microcephaly, developmental delay, seizures) | | **Fetal Bleeding** | No | Yes (intracranial hemorrhage, fetal death) | | **Optic Atrophy** | Rare | Yes (common) | | **Reversibility** | Permanent (structural) | Permanent (structural and hemorrhagic) | ### Warfarin Embryopathy (First Trimester) **High-Yield:** Classic triad: 1. **Nasal hypoplasia** (saddle nose deformity) 2. **Skeletal abnormalities** (stippled epiphyses, bone hypoplasia) 3. **Eye abnormalities** (optic nerve hypoplasia) These are structural malformations resulting from disruption of bone and cartilage development during organogenesis. ### Fetal Warfarin Syndrome (Second/Third Trimester) **High-Yield:** Occurs with continued warfarin exposure after organogenesis: 1. **CNS abnormalities** (microcephaly, developmental delay, seizures, intellectual disability) 2. **Optic atrophy** (leading cause of blindness) 3. **Fetal hemorrhage** (intracranial, intra-abdominal, leading to fetal death) These result from both structural CNS maldevelopment and hemorrhagic complications due to coagulopathy. ### Clinical Pearl **Mnemonic: "WARF" for Warfarin Risks in Pregnancy** - **W**arfarin Embryopathy = **1st trimester** → **Nasal hypoplasia, Skeletal abnormalities** - **A**rterial/CNS syndrome = **2nd/3rd trimester** → **Atrophy (optic), Abnormalities (CNS)** - **R**isk period = **6–12 weeks** for embryopathy; **any trimester** for fetal syndrome - **F**etal bleeding = **2nd/3rd trimester** → **Hemorrhage, Fetal death** ### Management Implications ```mermaid flowchart TD A[Pregnant woman on warfarin]:::outcome --> B{Gestational age?}:::decision B -->|First trimester| C[High risk of embryopathy]:::urgent C --> D[Switch to LMWH or UFH]:::action B -->|Second/third trimester| E[High risk of fetal syndrome]:::urgent E --> F[Continue anticoagulation with LMWH/UFH]:::action F --> G[Close fetal monitoring]:::action D --> H[Deliver at term hospital]:::action G --> H ``` **Warning:** Warfarin should be avoided in all trimesters if possible; LMWH or unfractionated heparin are preferred. However, some experts recommend warfarin in the second trimester (after organogenesis) as it carries lower hemorrhage risk than heparin in this period. [cite:Harrison 21e Ch 342]